Jeffrey J King, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 23033 N 4th St, Osage City, KS 66523 Phone: 785-528-3553 |
News Archive
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name Tcelna. The product, previously known as Tovaxin, will now be known as Tcelna as the company positions itself towards the treatment of patients with Secondary Progressive MS (SPMS).
Exercising, eating a healthy diet and playing brain games may help you keep your wits about you well into your 80s and even 90s, advises a new book by researchers at George Mason University.
A consortium of Quebec researchers coordinated by the Medical Genetics Service of the Sainte-Justine UHC has just published the findings of a 25-year study on the treatment of tyrosinemia, a life-threatening liver disease of genetic origin, which is screened at birth in the province of Quebec, where it is much more frequent than anywhere else in the world.
The North Texas Specialty Physicians (NTSP) Charitable Fund Board is pleased to announce the 2011 recipients of its patient care grant funding opportunities. The recipient organizations chosen serve the community and fit within the Charitable Fund's mission of "Driving innovations in the coordination and integration of safe and effective patient care in the North Texas Region."
An infant's odd case of rare encephalitis not typically found in children led researchers to discover never before seen genetic mutations and a more accurate technique to examine the IRAK4 gene responsible for innate immunity.
› Verified 6 days ago